Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase 1 and Phase 2a, First-in-human (FIH) Study, of DRP-104, a Broad Glutamine Antagonist, in Adult Patients with Advanced Solid Tumors.

JOURNAL OF CLINICAL ONCOLOGY(2021)

Cited 9|Views25
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined